Résultats de la recherche - Eric L. Simpson

Acitretin therapy for Galli-Galli disease par Chandler W. Rundle, MD, Solveig Ophaug, MD, Eric L. Simpson, MD, MCR

Accéder au texte intégral

Publisher Correction to: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry par Eric L. Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer

Accéder au texte intégral

Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry par Eric L. Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer

Accéder au texte intégral

Ruxolitinib Cream in Adolescents/Adults with Atopic Dermatitis Meeting Severity Thresholds for Systemic Therapy: Exploratory Analysis of Pooled Results from Two Phase 3 Studies par Eric L. Simpson, Leon Kircik, Andrew Blauvelt, Howard Kallender, Daniel Sturm, Mingyue Wang, Lawrence F. Eichenfield

Accéder au texte intégral

Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice par Melinda J. Gooderham, Andrew E. Pink, Eric L. Simpson, Jonathan I. Silverberg, Erman Güler, Melissa Watkins

Accéder au texte intégral

Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE par Jonathan I. Silverberg, Eric L. Simpson, Andrew E. Pink, Stephan Weidinger, Gary Chan, Pinaki Biswas, Claire Clibborn, Erman Güler

Accéder au texte intégral

Ruxolitinib cream monotherapy demonstrates rapid improvement in the extent and signs of mild to moderate atopic dermatitis across head and neck and other anatomic regions in adoles... par Eric L. Simpson, Robert Bissonnette, Zelma C. Chiesa Fuxench, Howard Kallender, Daniel Sturm, Haobo Ren, Linda F. Stein Gold

Accéder au texte intégral

Disease burden among patients with atopic dermatitis treated with systemic therapy for 4–12 months: results from the CorEvitas Atopic Dermatitis Registry par Jonathan I. Silverberg, Evangeline Pierce, Meghan Feely, Amber Reck Atwater, Amy Schrader, Eric A. Jones, Swapna S. Dave, Eric L. Simpson

Accéder au texte intégral

Clinically Meaningful Improvements in Adolescents with Moderate-to-Severe Atopic Dermatitis Treated with Tralokinumab who did not Achieve Clear or Almost Clear Skin at Week 16 par Amy S. Paller, Andrew Blauvelt, Weily Soong, H. Chih-ho Hong, Marie L. A. Schuttelaar, Shannon K. R. Schneider, Eric L. Simpson

Accéder au texte intégral

Restoring balance in atopic disorders: insights into type 2 immunity and chronic inflammation par Eric L. Simpson, Oscar Palomares, Brian S. Kim, Klaus F. Rabe, Klaus F. Rabe, Yamo Deniz, Antonio Martin, Rahin Ghassemebrahimzadeh, Sonya L. Cyr

Accéder au texte intégral

Tapinarof Improved Outcomes and Sleep for Patients and Families in Two Phase 3 Atopic Dermatitis Trials in Adults and Children par Eric L. Simpson, Adelaide A. Hebert, John Browning, Rocco T. Serrao, Howard Sofen, Philip M. Brown, Stephen C. Piscitelli, David S. Rubenstein, Anna M. Tallman

Accéder au texte intégral

Correction to: Qualitative Assessment of Adult Patients’ Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study par Bruno Falissard, Eric L. Simpson, Emma Guttman-Yassky, Kim A. Papp, Sebastien Barbarot, Abhijit Gadkari, Grece Saba, Laurene Gautier, Adeline Abbe, Laurent Eckert

Accéder au texte intégral

Qualitative Assessment of Adult Patients’ Perception of Atopic Dermatitis Using Natural Language Processing Analysis in a Cross-Sectional Study par Bruno Falissard, Eric L. Simpson, Emma Guttman-Yassky, Kim A. Papp, Sebastien Barbarot, Abhijit Gadkari, Grece Saba, Laurene Gautier, Adeline Abbe, Laurent Eckert

Accéder au texte intégral

Efficacy and safety of abrocitinib in patients with moderate‐to‐severe atopic dermatitis with prior exposure to oral systemic immunosuppressants or biologic therapies: A post hoc a... par Melinda J. Gooderham, Michael R. Ardern‐Jones, Emma Guttman‐Yassky, Mahreen Ameen, Eric L. Simpson, Gary Chan, Pinaki Biswas, Wing S. Chiu, Melissa Watkins

Accéder au texte intégral

Benefit–risk profile comparison between dupilumab and upadacitinib: a structured benefit–risk assessment of the Heads Up trial par Andrew Blauvelt, Eric L. Simpson, Kilian Eyerich, Marjolein de Bruin-Weller, Sebastien Barbarot, Peter A. Lio, William Hurst, Stephanie Tcherny-Lessenot, Stephane Levy, Mike Bastian

Accéder au texte intégral

Practical Management of the JAK1 Inhibitor Abrocitinib for Atopic Dermatitis in Clinical Practice: Special Safety Considerations par Melinda J. Gooderham, Marjolein de Bruin-Weller, Stephan Weidinger, Michael J. Cork, Lawrence F. Eichenfield, Eric L. Simpson, Athanasios Tsianakas, Urs Kerkmann, Claire Feeney, William Romero

Accéder au texte intégral

Safety of Baricitinib for the Treatment of Atopic Dermatitis in Adults Over a Median of 1.6 and up to 4.6 Years Treatment: Final Integrated Analysis of Eight Clinical Trials par Antonio Costanzo, Antonio Torrelo, Eric L. Simpson, Marjolein De Bruin‐Weller, Diamant Thaçi, Norito Katoh, Silvia Sabatino, Andrew Buchanan, Kasia Morawska, Samuel Ogwu, Karen Denning, Jonathan I. Silverberg

Accéder au texte intégral

Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry par Jonathan I. Silverberg, Linda Stein Gold, Seemal Desai, Alexandra Golant, Douglas DiRuggiero, D. Christian Fenske, Alvin Li, Zach Dawson, Yolanda Muñoz Maldonado, Kaylee Ho, Kayla Callahan, Eric L. Simpson

Accéder au texte intégral

Safety of baricitinib for the treatment of atopic dermatitis over a median of 1.6 years and up to 3.9 years of treatment: an updated integrated analysis of eight clinical trials par Thomas Bieber, Norito Katoh, Eric L. Simpson, Marjolein de Bruin-Weller, Diamant Thaçi, Antonio Torrelo, Angelina Sontag, Susanne Grond, Maher Issa, Xiaoyu Lu, Tracy Cardillo, Katrin Holzwarth, Jacob P. Thyssen

Accéder au texte intégral

History of S. aureus Skin Infection Significantly Associates with History of Eczema Herpeticum in Patients with Atopic Dermatitis par Mary C. Moran, Alanna Klose, Takeshi Yoshida, Anna De Benedetto, Lynda C. Schneider, Peck Y. Ong, Eric L. Simpson, Donald Y. M. Leung, Benjamin L. Miller, Christopher L. Seplaki, Lisa A. Beck

Accéder au texte intégral